Jan Stenvang

Medicine & Life Sciences

1. 1-(3-C-ethynylribopentofuranosyl)cytosine 47%
2. 1-(3-C-ethynylribopentofuranosyl)uracil 35%
3. Anthracyclines 16%
4. Biomarkers 59%
5. Breast Neoplasms 100%
6. Cell Line 49%
7. Colonic Neoplasms 15%
8. Colorectal Neoplasms 95%
9. DNA Methylation 20%
10. Docetaxel 26%
11. Drug Resistance 22%
12. Drug Therapy 22%
13. Estrogen Receptor Modulators 20%
14. Formaldehyde 18%
15. Gene Dosage 24%
16. Gene Expression 19%
17. Genes 26%
18. Irinotecan 77%
19. locked nucleic acid 56%
20. MCF-7 Cells 15%
21. Messenger RNA 15%
22. MicroRNAs 71%
23. Neoplasms 37%
24. Nucleosides 16%
25. Oligonucleotides 18%
26. Oxaliplatin 45%
27. Paraffin 19%
28. Pharmaceutical Preparations 24%
29. Progesterone Receptors 24%
30. Proteins 34%
31. Tamoxifen 17%
32. Therapeutics 22%
33. Tissue Inhibitor of Metalloproteinase-1 55%
34. Type I DNA Topoisomerase 22%